Invista to build world-scale adiponitrile facility in China by 2023
Invista announced that it has begun work to bring its latest adiponitrile (ADN) technology to China to meet the strong, local demand for the intermediate chemical, which is used to make nylon 6,6, fibres and other speciality materials such as hexamethylene diisocyanate (HDI) for polyurethane paints, coatings, and epoxy curing agents. According to the company, engineering for a minimum 300,000 t/y plant is underway at an estimated investment in excess of USD 1 billion. Construction start is targeted for 2020 and production would begin in 2023.
“Given China’s strong demand for ADN and its commitment to advanced, energy-efficient technologies, Invista’s butadiene-based ADN is the best choice for capital investment in the region,” said Kyle Redinger, vice president of Invista Intermediates, Asia Pacific. “Invista supplies more of the merchant market than any other ADN producer, so we want to ensure those customers have the best technology available. The last world-scale plant was constructed more than 35 years ago, so this is a special time for the industry, and I am extremely proud to lead Invista’s efforts to deliver this new facility.”
Bill Greenfield, president, Invista Intermediates, said, “We are pleased by the feedback we have received in the market and are confident we will reach agreements with selected partners over the next few months; so our shareholders have agreed to proceed with the project. Combined with the significant investments being made in our existing ADN plants, this decision further demonstrates Invista’s commitment to the global industry.”
Over the past five years, Invista has invested more than USD 600 million in China to support the nylon market, including a 215,000 t/y hexamethylenediamine (HMD) plant and a 150,000 t/y polymer plant, at the Shanghai Chemical Industry Park (SCIP).